CD274 and hepatocellular carcinoma: In addition, atezolizumab promoted the ubiquitination degradation of HBx and induced PD-L1 protein in HCC cells by activating 5’-adenosine monophosphate to activate the protein kinase pathway, which plays a more significant anti-tumor effect (91).